We analyzed the quantity of S100A4, S100A8, S100A9, and S100A12 immunopositive MNCs and CD19+ cells in CLL patients regardless of genetic abnormalities. The gene discussed is S100A4; the disease is B-cell chronic lymphocytic leukemia.